{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:19:38Z","timestamp":1788952778014,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP19fk0108113"],"award-info":[{"award-number":["JP19fk0108113"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP223fa727001"],"award-info":[{"award-number":["JP223fa727001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP223fa627002"],"award-info":[{"award-number":["JP223fa627002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP22gm1610010"],"award-info":[{"award-number":["JP22gm1610010"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H02521"],"award-info":[{"award-number":["JP22H02521"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K09264"],"award-info":[{"award-number":["JP24K09264"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021834","name":"The University of Osaka Research Institute for Microbial Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.isci.2026.114851","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:42:49Z","timestamp":1769733769000},"page":"114851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Broad-spectrum antiviral activity of antisense oligonucleotides targeting GBF1 against SARS-CoV-2 and influenza viruses"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2820-6690","authenticated-orcid":false,"given":"Victoria","family":"Simanihuruk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurie","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harumi","family":"Yamaguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Kameoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuki","family":"Anzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Shichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Obika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuya","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6461-5379","authenticated-orcid":false,"given":"Tokiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.114851_bib1","series-title":"Influenza (seasonal)","year":"2025"},{"key":"10.1016\/j.isci.2026.114851_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.114851_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35431","article-title":"Emerging SARS-CoV-2 Resistance After Antiviral Treatment","volume":"7","author":"Tamura","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.isci.2026.114851_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cid\/ciad494","article-title":"Nirmatrelvir Resistance\u2014de Novo E166V\/L50V Mutations in an Immunocompromised Patient Treated With Prolonged Nirmatrelvir\/Ritonavir Monotherapy Leading to Clinical and Virological Treatment Failure\u2014a Case Report","volume":"78","author":"Zuckerman","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2026.114851_bib6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3201\/eid1606.091623","article-title":"Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan","volume":"16","author":"Ujike","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.isci.2026.114851_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.114851_bib8","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1038\/s41467-023-37826-w","article-title":"Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy","volume":"14","author":"Ragonnet-Cronin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114851_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/v16020217","article-title":"Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants","volume":"16","author":"Focosi","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.114851_bib10","series-title":"Therapeutics and COVID-19: Living Guideline, 10 November 2023","year":"2023"},{"key":"10.1016\/j.isci.2026.114851_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrmicro2692","article-title":"The dependence of viral RNA replication on co-opted host factors","volume":"10","author":"Nagy","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.114851_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007587","article-title":"Host factor prioritization for pan-viral genetic perturbation screens using random intercept models and network propagation","volume":"16","author":"Dirmeier","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.isci.2026.114851_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41467-019-13965-x","article-title":"Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114851_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00127-23","article-title":"Genome-Scale CRISPR Screening Reveals Host Factors Required for Ribosome Formation and Viral Replication","volume":"14","author":"Ohlson","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.isci.2026.114851_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41467-023-44175-1","article-title":"Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection","volume":"15","author":"Hou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114851_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110475","article-title":"Genome-scale CRISPR-Cas9 screen identifies host factors as potential therapeutic targets for SARS-CoV-2 infection","volume":"27","author":"Sakai","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.114851_bib17","article-title":"A review of virus host factor discovery using CRISPR screening","volume":"15","author":"See, W.R.","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.isci.2026.114851_bib18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/v12060682","article-title":"Role of the Guanine Nucleotide Exchange Factor GBF1 in the Replication of RNA Viruses","volume":"12","author":"Mart\u00ednez","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.114851_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116069","article-title":"Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses","volume":"265","author":"He","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.isci.2026.114851_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01857-23","article-title":"Systematic review and meta-analysis of genome-wide pooled CRISPR screens to identify host factors involved in influenza A virus infection","volume":"98","author":"Maes","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.114851_bib21","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3390\/ijms26041481","article-title":"Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses","volume":"26","author":"Luong","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114851_bib22","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/v12121394","article-title":"IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro","volume":"12","author":"Hahn","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.114851_bib23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.abf4058","article-title":"Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A","volume":"371","author":"White","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.114851_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/v15010105","article-title":"Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases","volume":"15","author":"Afowowe","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.114851_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/v15020319","article-title":"EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells","volume":"15","author":"Foret-Lucas","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.114851_bib26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.chom.2023.05.030","article-title":"Generation of host-directed and virus-specific antivirals using targeted protein degradation promoted by small molecules and viral RNA mimics","volume":"31","author":"Zhao","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2026.114851_bib27","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.chembiol.2024.10.009","article-title":"Host specific sphingomyelin is critical for replication of diverse RNA viruses","volume":"31","author":"Han","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2026.114851_bib28","doi-asserted-by":"crossref","first-page":"14586","DOI":"10.1021\/acs.jmedchem.4c01402","article-title":"Discovery of Potent STT3A\/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and Safety","volume":"67","author":"Pero","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.114851_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.114851_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.114851_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40291-021-00573-z","article-title":"Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension","volume":"26","author":"Yasuhara","year":"2022","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.isci.2026.114851_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102272","article-title":"Construction of a Tm-value prediction model and molecular dynamics study of AmNA-containing gapmer antisense oligonucleotide","volume":"35","author":"Kuroda","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.isci.2026.114851_bib33","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1038\/s41598-019-43100-1","article-title":"A gapmer antisense oligonucleotide targeting SRRM4 is a novel therapeutic medicine for lung cancer","volume":"9","author":"Shimojo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.114851_bib34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.omtn.2020.10.001","article-title":"Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric Cancer","volume":"22","author":"Kanda","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.isci.2026.114851_bib35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chom.2014.11.002","article-title":"Influenza Virus-Host Interactome Screen as a Platform for Antiviral Drug Development","volume":"16","author":"Watanabe","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2026.114851_bib36","first-page":"71","article-title":"Gbf1: A Novel Golgi-Associated Bfa-Resistant Guanine Nucleotide Exchange Factor That Displays Specificity for Adp-Ribosylation Factor 5","volume":"146","author":"Claude","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.isci.2026.114851_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1034\/j.1600-0854.2002.30705.x","article-title":"GBF1, a guanine nucleotide exchange factor for ADP-ribosylation factors, is localized to the cis-Golgi and involved in membrane association of the COPI coat","volume":"3","author":"Kawamoto","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.isci.2026.114851_bib38","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1242\/jcs.010769","article-title":"Dissecting the role of the ARF guanine nucleotide exchange factor GBF1 in Golgi biogenesis and protein trafficking","volume":"120","author":"Szul","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.isci.2026.114851_bib39","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1242\/jcs.03173","article-title":"GBF1, a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi protein traffic","volume":"119","author":"Zhao","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.isci.2026.114851_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/embor.2008.221","article-title":"A COPI coat subunit interacts directly with an early-Golgi localized Arf exchange factor","volume":"10","author":"Deng","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.isci.2026.114851_bib41","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1016\/S0040-4039(97)10322-7","article-title":"Synthesis of 2\u2019-O,4\u2019-C-Methyleneuridine and -Cytidine. Novel Bicyclic Nucleosides Having a Fixed C3\u2019-Endo Sugar Puckering","volume":"38","author":"Obika","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.isci.2026.114851_bib42","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1016\/S0040-4039(98)01084-3","article-title":"Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2\u2032-O,4\u2032-C-methyleneribonucleosides","volume":"39","author":"Obika","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.isci.2026.114851_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1039\/a708608c","article-title":"LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition","author":"Singh","year":"1998","journal-title":"Chem. Commun."},{"key":"10.1016\/j.isci.2026.114851_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv626","article-title":"Ca2+ enrichment in culture medium potentiates effect of oligonucleotides","volume":"43","author":"Hori","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.114851_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nchembio.144","article-title":"Golgicide A reveals essential roles for GBF1 in Golgi assembly and function","volume":"5","author":"S\u00e1enz","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2026.114851_bib46","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1091\/mbc.e02-11-0730","article-title":"ADP-ribosylation factor\/COPI-dependent events at the endoplasmic reticulum-Golgi interface are regulated by the guanine nucleotide exchange factor GBF1","volume":"14","author":"Garc\u00eda-Mata","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.isci.2026.114851_bib47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1091\/mbc.e07-04-0394","article-title":"Distinct functions for Arf guanine nucleotide exchange factors at the Golgi complex: GBF1 and BIGs are required for assembly and maintenance of the Golgi stack and trans-Golgi network, respectively","volume":"19","author":"Manolea","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.isci.2026.114851_bib48","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1462-5822.2010.01482.x","article-title":"Poliovirus replication requires the N-terminus but not the catalytic Sec7 domain of ArfGEF GBF1","volume":"12","author":"Belov","year":"2010","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.isci.2026.114851_bib49","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/cmi.12572","article-title":"Identification of class II ADP-ribosylation factors as cellular factors required for hepatitis C virus replication","volume":"18","author":"Farhat","year":"2016","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.isci.2026.114851_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12038-016-9659-0","article-title":"CSFV proliferation is associated with GBF1 and Rab2","volume":"42","author":"Liang","year":"2017","journal-title":"J. Biosci."},{"key":"10.1016\/j.isci.2026.114851_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01751-17","article-title":"Viperin Targets Flavivirus Virulence by Inducing Assembly of Noninfectious Capsid Particles","volume":"92","author":"Vonderstein","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.114851_bib52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0962-8924(99)01699-2","article-title":"Turning on ARF: the Sec7 family of guanine-nucleotide-exchange factors","volume":"10","author":"Jackson","year":"2000","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.isci.2026.114851_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000088","article-title":"Mouse Hepatitis Coronavirus RNA Replication Depends on GBF1-Mediated ARF1 Activation","volume":"4","author":"Verheije","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.114851_bib54","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/JVI.01826-09","article-title":"Integrity of the Early Secretory Pathway Promotes, but Is Not Required for, Severe Acute Respiratory Syndrome Coronavirus RNA Synthesis and Virus-Induced Remodeling of Endoplasmic Reticulum Membranes","volume":"84","author":"Knoops","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.114851_bib55","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1128\/JVI.01029-15","article-title":"A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins","volume":"89","author":"De Wilde","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.114851_bib56","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1099\/jgv.0.001099","article-title":"Investigation of the role of GBF1 in the replication of positive-sense single-stranded RNA viruses","volume":"99","author":"Ferlin","year":"2018","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.isci.2026.114851_bib57","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.apsb.2023.03.015","article-title":"The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses","volume":"13","author":"Wu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2026.114851_bib58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41579-023-01003-z","article-title":"SARS-CoV-2 biology and host interactions","volume":"22","author":"Steiner","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.114851_bib59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/path.2993","article-title":"Gene silencing by siRNAs and antisense oligonucleotides in the laboratory and the clinic","volume":"226","author":"Watts","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2026.114851_bib60","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1038\/s41467-022-32216-0","article-title":"An intranasal ASO therapeutic targeting SARS-CoV-2","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.114851_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102331","article-title":"Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA","volume":"35","author":"Sakai","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.isci.2026.114851_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105992","article-title":"Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA","volume":"230","author":"Yamasaki","year":"2024","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2026.114851_bib63","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/nat.2016.0619","article-title":"Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication","volume":"26","author":"Lenartowicz","year":"2016","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.isci.2026.114851_bib64","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115298","article-title":"A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant","volume":"14","author":"Chang","year":"2022","journal-title":"EMBO Mol. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226002269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226002269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:01:13Z","timestamp":1788951673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226002269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2589004226002269"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.114851","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broad-spectrum antiviral activity of antisense oligonucleotides targeting GBF1 against SARS-CoV-2 and influenza viruses","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.114851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114851"}}